LifeSci Capital Starts Monte Rosa Therapeutics (GLUE) at Outperform
Tweet
Share
E-mailGet Alerts GLUE Hot Sheet
Price: $15.50 -2.15%
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
LifeSci Capital initiates coverage on Monte Rosa Therapeutics (NASDAQ: GLUE) with a Outperform rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Monte Rosa Therapeutics click here. For more ratings news on Monte Rosa Therapeutics click here.
Shares of Monte Rosa Therapeutics closed at $6.11 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Canaccord Starts Galiano Gold (GAU:CN) at Buy
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
